BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Depar FN, Chaudhary AJ, Hameed J, Abbasi FS, Uzma B, Ali A, Akhtar N, Khan R, Siddiqi A, Riaz S. Cancer stem cell markers, chemotherapy response, and survival in triple-negative breast cancer. World J Clin Oncol 2026; 17(2): 116251 [PMID: 41810343 DOI: 10.5306/wjco.v17.i2.116251]
URL: https://www.wjgnet.com/2218-4333/full/v17/i2/116251.htm
Number Citing Articles
1
Ilya Klabukov, Denis Baranovskii, Daria Eygel, Elena Yatsenko. Letter to the Editor: Cancer stem cell and oncomatrix biomarkers predict chemotherapy response and survival in triple-negative breast cancer. World Journal of Clinical Oncology 2026; 17(7): 120955 doi: 10.5306/wjco.120955
2
Zhenhong Du, Gang Tu, Lingfeng Tang. Interpretable machine learning reveals the synergistic impact of essential hypertension on early recurrence in triple-negative breast cancer. Scientific Reports 2026; 16(1) doi: 10.1038/s41598-026-59274-4
3
Sunil V Jagtap, Shubham S Jagtap. Prognostic significance of stem cell markers: In triple-negative breast cancers. World Journal of Clinical Oncology 2026; 17(7): 119673 doi: 10.5306/wjco.v17.i7.119673
4
Hatice Asoglu, Esra Asarkaya, Abdurrahman Aykut, Gunes Dorukhan Cavusoglu, Yasemin Aydinalp Camadan, Mehmet Mutlu Kidi, Sedat Biter, Sendag Yaslikaya, Ramazan Asoglu, Tugba Toyran, Melek Ergin, Ertugrul Bayram, Ismail Oguz Kara, Berksoy Sahin, Semra Paydas, Tolga Koseci. Pre-Treatment CD44 and CD47 Expression and Pathological Complete Response After Neoadjuvant Therapy in Breast Cancer: An Exploratory Single-Center Study. International Journal of Molecular Sciences 2026; 27(21) doi: 10.3390/ijms27219671
5
Tian Fang, Mengxing Zhang, Chang Ma, Min Dong, Xinhao Song, Junqi Wang, Runan Zuo, Jinwei You, Yingfeng Zhao, Shanxiang Jiang, Dawei Guo. Enhancing EGFR Inhibition: Monensin and Erlotinib Synergize to Eliminate Cancer Stem Cells in Canine Mammary Tumours. Veterinary and Comparative Oncology 2026; 24(3) doi: 10.1111/vco.70085